Research and Markets : This is The Only Product That Provides You with a Comprehensive Picture of the Development of Cancer Vaccines.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c19295) has announced the addition of Analytical Tool - Cancer Vaccine The term cancer vaccine is often used to describe a process whereby a person's immune system is coaxed into recognizing and destroying malignant cells without harming normal cells. to their offering. This is our second analytical tool in the cancer vaccine field, now more updated and extensive. We have since several years continuously studied the progress in cancer immunotherapy Cancer immunotherapy is the use of the immune system to reject cancer. The main premise is stimulating the patient's immune system to attack the malignant tumor cells that are responsible for the disease. strategies. So far "passive" immunotherapy has experienced most success, with antibody and cytokine Cytokine Any of a group of soluble proteins that are released by a cell to send messages which are delivered to the same cell (autocrine), an adjacent cell (paracrine), or a distant cell (endocrine). therapy leading the way. Among the strategies utilizing an active immunotherapy active immunotherapy The administration of substances to evoke a protective immune response in the form of specific antibodies. Cf Passive immunotherapy, Vaccine. approach it is evident that cell-based vaccines have made most progress. Positive data has been forth coming for a whole cell melanoma vaccine, for a vaccine based on the patient's own surgically removed tumor cells and dendritic cells pulsed for the treatment of advanced prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. . The latest strategies that have emerged are to modulate immuno-surveillance, antigen processing Antigen processing is a biological process that prepares antigens for presentation to special cells of the immune system called T lymphocytes. This process involves two distinct pathways for processing of antigens from an organism's own (self) proteins or intracellular pathogens (e. and presentation. Although immune cells infiltrate tumors, they are frequently unable to mount a full-scale attack, because tolerance mechanisms prevent them from destroying cells that express self-antigens. "Analytical Tool: Cancer Vaccine" is the ultimate tool for serious players who would like to understand the current competitive field in cancer vaccine development. Those who are victorious in the field plan effectively and change decisively. It provides a complete and systematic description and analysis of the past, present and future efforts in cancer R&D from both industry as well as academic. We have identified, structured and defined information necessary to analyze the most candidates currently under development. Our included CD-ROM CD-ROM: see compact disc. CD-ROM in full compact disc read-only memory Type of computer storage medium that is read optically (e.g., by a laser). database contains thousands of records on the issue of R&D and collaborations from a multitude of sources. This highly updated database reflects the most recent advances in the field. This in order to help you perform your own specific analysis, go back to the source data for in-depth information, and to offer you an opportunity to easily produce tables and graphs of the information suited for your own specific purposes. Reasons to read this Analytical Tool: --This is the only product that provides you with a comprehensive picture of the development of cancer vaccines Cancer vaccines A treatment that uses the patient's immune system to attack cancer cells. Mentioned in: Pancreatic Cancer, Exocrine . --It identifies and structures most B2B (Business to Business) Refers to one business communicating with or selling to another. See B2B e-commerce, B2C and B2G. B2B - business to business collaborations and industry-academic alliances --It covers close to all areas of cancer therapeutic strategies --You will be able to study areas in conjunction to cancer structured by therapy type, drug effects, mechanisms/targets and combinatory therapies --It enables you to track cutting edge competitive companies, therapies and technologies in the future market --You will save time and money by rapid identification and analysis of competitors and business opportunities. --You will be able to evaluate progress in both established as well as novel treatment strategies competing within the field. "Analytical Tool: Cancer Vaccines" offers a unique tool for analyzing the complex competitive pressure within this field. It is at the same time a map of the research and development, an up to date history of the achievements and a guide pointing out the directions of the future. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. This Analytical Tool includes four parts: Cancer Vaccines: Fantasy & Future? Tumor Antigens & Cancer Vaccines Basic Platform Report: Cancer Vaccines Business Development and R&D Database: Cancer Vaccines Example of candidates included: Actimmune, Allovectin-7, Avicine, BEC2, Canvaxin, CeaVac, CaPVax. (DCVax), Gastrimmune, GMK GMK Grand Master Key (locksmithing) GMK Gnu Make File , LymphoCide, Melacine, M-Vax, MyVax, Oncophage, OncoVAX, Osidem, Ovarex, Provenge, Theratope, TriGem, TroVax and many more. Companies Mentioned: AltaRex, Aphton, Antigenics, Antisoma, Abbott, AVAX Technologies, AVI Biopharma, Biogen Idec, Biomira, Bristol-Myers Squibb, CancerVax, Celgene, Corixa, Dendreon, Genentech, Genitope, GlaxoSmithKline, Igeneon, ILEX Ilex a bush bearing berries containing saponins; cause vomiting, diarrhea. Called also holly. Oncology, ImClone System, Immuno-Designed Molecules, IDM (1) See identity management. (2) (Integrated Device Manufacturer) A company that performs every step of the chip-making process, including design, manufacture, test and packaging. Examples of IDMs are Intel, AMD, Motorola, IBM, TI and Lucent. , Immunomedics, Intermune, Intracel, Medarex, Merck, Northwest Biotherapeutics, Oxford Biomedica, Progenics Pharma, Protein Design Labs, Roche, Vical, Schering AG and many more. For more information visit http://www.researchandmarkets.com/reports/c19295 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion